Morgan Stanley
TLX

Morgan Stanley’s Telix Pharmaceuticals TLX Stock Holding History

Morgan Stanley’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
116,440
+98,787
+560% +$753K ﹤0.01% 5080
2025
Q4 		$132K Buy
17,653
+14,419
+446% +$139K ﹤0.01% 6085
2025
Q3 		$30.9K Sell
3,234
-1,168
-27% -$14.3K ﹤0.01% 6557
2025
Q2 		$70.7K Sell
4,402
-1,232
-22% -$20.7K ﹤0.01% 6245
2025
Q1 		$94.4K Buy
+5,634
New +$98.4K ﹤0.01% 6038

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.7B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $6.95B AUM 29.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return